186 related articles for article (PubMed ID: 23504411)
1. Factors that influence awareness and treatment of atrial fibrillation in older adults.
Frewen J; Finucane C; Cronin H; Rice C; Kearney PM; Harbison J; Kenny RA
QJM; 2013 May; 106(5):415-24. PubMed ID: 23504411
[TBL] [Abstract][Full Text] [Related]
2. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
[TBL] [Abstract][Full Text] [Related]
3. Improving anticoagulation in atrial fibrillation: observational study in three primary care trusts.
Robson J; Dostal I; Mathur R; Sohanpal R; Hull S; Antoniou S; Maccallum P; Schilling R; Ayerbe L; Boomla K
Br J Gen Pract; 2014 May; 64(622):e275-81. PubMed ID: 24771841
[TBL] [Abstract][Full Text] [Related]
4. The atrial fibrillation in Turkey: Epidemiologic Registry (AFTER).
Ertas F; Eren NK; Kaya H; Aribas A; Acar G; Kanadasi M; Gedik S; Oylumlu M; Yuksel M; Ulgen MS;
Cardiol J; 2013; 20(4):447-52. PubMed ID: 23677730
[TBL] [Abstract][Full Text] [Related]
5. [A Censis survey on atrial fibrillation awareness in the general population and among general practitioners and affected patients in Italy].
Gensini GF; Di Pasquale G; Vaccaro CM; Riva L; Iori I; Nozzoli C; Pengo V; Ricci S; Santini M; Toni D
G Ital Cardiol (Rome); 2014 Jan; 15(1):37-43. PubMed ID: 24503733
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of atrial fibrillation in a geographically well-defined population in northern Sweden: implications for anticoagulation prophylaxis.
Andersson P; Löndahl M; Abdon NJ; Terent A
J Intern Med; 2012 Aug; 272(2):170-6. PubMed ID: 22250988
[TBL] [Abstract][Full Text] [Related]
7. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of undiagnosed atrial fibrillation and of that not being treated with anticoagulant drugs: the AFABE study.
Clua-Espuny JL; Lechuga-Duran I; Bosch-Princep R; Roso-Llorach A; Panisello-Tafalla A; Lucas-Noll J; López-Pablo C; Queralt-Tomas L; Giménez-Garcia E; González-Rojas N; Gallofré López M
Rev Esp Cardiol (Engl Ed); 2013 Jul; 66(7):545-52. PubMed ID: 24776203
[TBL] [Abstract][Full Text] [Related]
9. Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation.
Lip GY; Laroche C; Boriani G; Cimaglia P; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Popescu MI; Tica O; Hellum CF; Mortensen B; Tavazzi L; Maggioni AP
Europace; 2015 Jan; 17(1):24-31. PubMed ID: 24957921
[TBL] [Abstract][Full Text] [Related]
10. Adenosine diphosphate-induced platelet aggregation might contribute to poor outcomes in atrial fibrillation-related ischemic stroke.
Choi JH; Cha JK; Huh JT
J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):e215-20. PubMed ID: 24274935
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of renal dysfunction according to the type of atrial fibrillation and anticoagulation treatment in patients who attended primary care in Spain.
Barrios V; Escobar C; Calderón A; Zamorano JL
Future Cardiol; 2014 Mar; 10(2):215-20. PubMed ID: 24762248
[TBL] [Abstract][Full Text] [Related]
12. Atrial fibrillation in chronic hemodialysis patients: prevalence, types, predictors, and treatment practices in Greece.
Tsagalis G; Bakirtzi N; Manios E; Chouliaras I; Papagiannidou P; Stamellou E; Akrivos T; Makris F; Psimenou E; Koutroubas G; Xinos K; Vemmos K
Artif Organs; 2011 Oct; 35(10):916-22. PubMed ID: 21615429
[TBL] [Abstract][Full Text] [Related]
13. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
[TBL] [Abstract][Full Text] [Related]
14. AF is associated with self-reported syncope and falls in a general population cohort.
Jansen S; Frewen J; Finucane C; de Rooij SE; van der Velde N; Kenny RA
Age Ageing; 2015 Jul; 44(4):598-603. PubMed ID: 25712516
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
[TBL] [Abstract][Full Text] [Related]
16. Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients.
Wilke T; Groth A; Mueller S; Pfannkuche M; Verheyen F; Linder R; Maywald U; Kohlmann T; Feng YS; Breithardt G; Bauersachs R
Thromb Haemost; 2012 Jun; 107(6):1053-65. PubMed ID: 22398417
[TBL] [Abstract][Full Text] [Related]
17. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
[TBL] [Abstract][Full Text] [Related]
18. Prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients with incident non-valvular atrial fibrillation.
Haim M; Hoshen M; Reges O; Rabi Y; Balicer R; Leibowitz M
J Am Heart Assoc; 2015 Jan; 4(1):e001486. PubMed ID: 25609415
[TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation and use of antithrombotic medications in older people: A population-based study.
Ding M; Fratiglioni L; Johnell K; Fastbom J; Ljungdahl M; Qiu C
Int J Cardiol; 2017 Dec; 249():173-178. PubMed ID: 29121723
[TBL] [Abstract][Full Text] [Related]
20. CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.
Ntaios G; Lip GY; Makaritsis K; Papavasileiou V; Vemmou A; Koroboki E; Savvari P; Manios E; Milionis H; Vemmos K
Neurology; 2013 Mar; 80(11):1009-17. PubMed ID: 23408865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
